Participation in Research and Access to Experimental Treatments by HIV-Infected Patients
Authors:
- Allen L. GiffordAGAllen L. Gifford
- William E. CunninghamWCWilliam E. Cunningham
- Kevin C. HeslinKHKevin C. Heslin
- Ron M. AndersenRARon M. Andersen
- Terry NakazonoTNTerry Nakazono
- Dale K. LieuDLDale K. Lieu
- Martin F. ShapiroMSMartin F. Shapiro
- Samuel A. BozzetteSBSamuel A. Bozzette
- 2 May 2002
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 346 (18) , 1373-1382
Abstract
Although there is concern that minority groups and women are underrepresented in research involving patients with human immunodeficiency virus (HIV) infection, the available data are inconclusive.Keywords
This publication has 26 references indexed in Scilit:
- Do Blacks Believe That HIV/AIDS Is a Government Conspiracy against Them?Preventive Medicine, 1999
- Influence of Race or Ethnicity on Pharmacokinetics of DrugsJournal of Pharmaceutical Sciences, 1997
- Race, Gender, Drug Use, and Participation in AIDS Clinical Trials Lessons from a Municipal Hospital CohortJournal of General Internal Medicine, 1997
- Zidovudine Side Effects As Reported by Black, Hispanic, and White/Non-Hispanic Patients with Early HIV Disease: Combined Analysis of Two Multicenter Placebo-Controlled TrialsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Differences in Participation in Experimental Drug Trials Among Persons With AIDSJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Expanded Distribution of an Investigational Drug in Parallel with Ongoing Controlled Clinical Trials: The Didanosine ModelClinical Infectious Diseases, 1994
- Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosinePatient Education and Counseling, 1994
- The Didanosine Expanded Access Program: Safety AnalysisClinical Infectious Diseases, 1993
- Zidovudine. Does it work for everyone?1991
- Representation of American blacks in clinical trials of new drugsJAMA, 1989